Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Effects of cannabinoid receptor agonist WIN 55,212-2 on blood-brain barrier disruption in focal cerebral ischemia in rats.

Chi OZ, Barsoum S, Grayson J, Hunter C, Liu X, Weiss HR.

Pharmacology. 2012;89(5-6):333-8. doi: 10.1159/000338755.

PMID:
22678129
2.
3.

Effects of GABA(A) receptor blockade on regional cerebral blood flow and blood-brain barrier disruption in focal cerebral ischemia.

Chi OZ, Hunter C, Liu X, Chi Y, Weiss HR.

J Neurol Sci. 2011 Feb 15;301(1-2):66-70. doi: 10.1016/j.jns.2010.10.024. Epub 2010 Nov 20.

PMID:
21094956
4.

Effects of anti-VEGF antibody on blood-brain barrier disruption in focal cerebral ischemia.

Chi OZ, Hunter C, Liu X, Weiss HR.

Exp Neurol. 2007 Mar;204(1):283-7. Epub 2006 Dec 22.

PMID:
17188266
5.

Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats.

Järbe TU, LeMay BJ, Olszewska T, Vemuri VK, Wood JT, Makriyannis A.

Pharmacol Biochem Behav. 2008 Nov;91(1):84-90. doi: 10.1016/j.pbb.2008.06.014. Epub 2008 Jun 29.

6.

Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia.

Muthian S, Rademacher DJ, Roelke CT, Gross GJ, Hillard CJ.

Neuroscience. 2004;129(3):743-50.

PMID:
15541895
7.

Effects of the thioredoxin-1 inhibitor PX-12 on blood-brain barrier permeability in the early stage of focal cerebral ischemia.

Chi OZ, Barsoum S, Grayson J, Liu X, Weiss HR.

Pharmacology. 2013;92(3-4):175-81. doi: 10.1159/000354583. Epub 2013 Sep 21.

PMID:
24060905
8.

Effects of blockade of ionotropic glutamate receptors on blood-brain barrier disruption in focal cerebral ischemia.

Liu X, Hunter C, Weiss HR, Chi OZ.

Neurol Sci. 2010 Dec;31(6):699-703. doi: 10.1007/s10072-010-0241-5. Epub 2010 Mar 9.

PMID:
20217443
9.

Effects of SR141716 and WIN 55,212-2 on tolerance to ethanol in rats using the acute and rapid procedures.

Lemos JI, Takahashi RN, Morato GS.

Psychopharmacology (Berl). 2007 Oct;194(2):139-49. Epub 2007 Jun 3.

PMID:
17546513
10.

Effects of erythropoietin on blood-brain barrier disruption in focal cerebral ischemia.

Chi OZ, Hunter C, Liu X, Weiss HR.

Pharmacology. 2008;82(1):38-42. doi: 10.1159/000127839. Epub 2008 Apr 24.

PMID:
18434762
12.

The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats.

Pamplona FA, Prediger RD, Pandolfo P, Takahashi RN.

Psychopharmacology (Berl). 2006 Nov;188(4):641-9. Epub 2006 Sep 1.

PMID:
16947018
13.

Neuroprotective effect of WIN 55,212-2 pretreatment against focal cerebral ischemia through activation of extracellular signal-regulated kinases in rats.

Hu B, Wang Q, Chen Y, Du J, Zhu X, Lu Y, Xiong L, Chen S.

Eur J Pharmacol. 2010 Oct 25;645(1-3):102-7. doi: 10.1016/j.ejphar.2010.07.024. Epub 2010 Jul 25.

PMID:
20667450
14.

Effects of 17beta-estradiol on blood-brain barrier disruption during focal ischemia in rats.

Chi OZ, Liu X, Weiss HR.

Horm Metab Res. 2002 Sep;34(9):530-4.

PMID:
12384831
15.
16.

Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.

Castelli MP, Paola Piras A, D'Agostino A, Pibiri F, Perra S, Gessa GL, Maccarrone M, Pistis M.

Eur J Pharmacol. 2007 Nov 14;573(1-3):11-9. Epub 2007 Jul 4.

PMID:
17644084
17.

Cannabinoid 1 receptors modulate intestinal sensory and motor function in rat.

Yüce B, Kemmer M, Qian G, Müller M, Sibaev A, Li Y, Kreis ME, Storr M.

Neurogastroenterol Motil. 2010 Jun;22(6):672-e205. doi: 10.1111/j.1365-2982.2010.01473.x. Epub 2010 Feb 18.

18.

WIN 55212-2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors.

Pamplona FA, Takahashi RN.

Neurosci Lett. 2006 Apr 10-17;397(1-2):88-92. Epub 2006 Jan 6.

PMID:
16406322
19.

Cannabinoid type 1 receptor ligands WIN 55,212-2 and AM 251 alter anxiety-like behaviors of marmoset monkeys in an open-field test.

Cagni P, Barros M.

Behav Brain Res. 2013 Mar 1;240:91-4. doi: 10.1016/j.bbr.2012.11.018. Epub 2012 Nov 23.

PMID:
23183218
20.

Memory encoding in hippocampal ensembles is negatively influenced by cannabinoid CB1 receptors.

Hampson RE, Sweatt AJ, Goonawardena AV, Song D, Chan RH, Marmarelis VZ, Berger TW, Deadwyler SA.

Behav Pharmacol. 2011 Aug;22(4):335-46. doi: 10.1097/FBP.0b013e3283473bfd.

Supplemental Content

Support Center